Generation Bio Co reports results for the quarter ended in December - Earnings Summary

Generation Bio

23/02/2023 23:21

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 55 cents​​ per share for the quarter ended in December. The
mean expectation of eight analysts for the quarter was for a
loss of 58 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 55 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Generation Bio Co shares had risen by 12.0% this quarter.
    * The company reported a quarterly loss of $32.41 million.
    * Wall Street's median 12-month price target for Generation
Bio Co
is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
23 at 11:20 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.58          -0.55          Beat
 Sep. 30 2022      -0.67          -0.53          Beat
 Jun. 30 2022      -0.62          -0.66          Missed
 Mar. 31 2022      -0.52          -0.61          Missed